# Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-the-terminal-complement-inhibitor-eculizumab-in-japanese/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuzuru Kanakura,Kazuma Ohyashiki,Tsutomu Shichishima,Shinichiro Okamoto,Kiyoshi Ando,Haruhiko Ninomiya,Tatsuya Kawaguchi,Shinji Nakao,Hideki Nakakuma,J Nishimura,Taroh Kinoshita,Camille L. Bedrosian,Marye Ellen Valentine,Gus Khursigara,Keiya Ozawa,Mitsuhiro Omine |
| Citations | 72 |
| DOI | 10.1007/s12185-010-0748-9 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1985521042 |
| PMID | 21222185 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Yuzuru Kanakura](https://scholariq.org/researchers/yuzuru-kanakura/)
- [Keiya Ozawa](https://scholariq.org/researchers/keiya-ozawa/)
- [Taroh Kinoshita](https://scholariq.org/researchers/taroh-kinoshita/)
- [Shinji Nakao](https://scholariq.org/researchers/shinji-nakao/)
- [Kiyoshi Ando](https://scholariq.org/researchers/kiyoshi-ando/)

## Paper funders

- [Japan Society for the Promotion of Science](https://scholariq.org/funders/japan-society-for-the-promotion-of-science/)

## Paper journal

- [International Journal of Hematology](https://scholariq.org/journals/international-journal-of-hematology/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.